S&P 500   5,254.35
DOW   39,807.40
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
Foot Locker Builds Up Another Head of Steam; Gains Imminent
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
Algeria's government pushes staples to subsidized markets to stave off Ramadan shortages
S&P 500   5,254.35
DOW   39,807.40
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
Foot Locker Builds Up Another Head of Steam; Gains Imminent
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
Algeria's government pushes staples to subsidized markets to stave off Ramadan shortages
S&P 500   5,254.35
DOW   39,807.40
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
Foot Locker Builds Up Another Head of Steam; Gains Imminent
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
Algeria's government pushes staples to subsidized markets to stave off Ramadan shortages
S&P 500   5,254.35
DOW   39,807.40
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
Foot Locker Builds Up Another Head of Steam; Gains Imminent
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
Algeria's government pushes staples to subsidized markets to stave off Ramadan shortages

Enovis (ENOV) Stock Price, News & Analysis

$62.38
-0.08 (-0.13%)
(As of 03/28/2024 ET)
Today's Range
$61.95
$62.62
50-Day Range
$58.70
$63.80
52-Week Range
$43.04
$66.14
Volume
351,475 shs
Average Volume
390,621 shs
Market Capitalization
$3.42 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$75.43

Enovis MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
20.9% Upside
$75.43 Price Target
Short Interest
Bearish
8.38% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.63mentions of Enovis in the last 14 days
Based on 4 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
18.22%
From $2.58 to $3.05 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.03 out of 5 stars

Medical Sector

403rd out of 939 stocks

Surgical Appliances & Supplies Industry

12th out of 18 stocks

ENOV stock logo

About Enovis Stock (NYSE:ENOV)

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.

ENOV Stock Price History

ENOV Stock News Headlines

ENOV Dec 2024 60.000 put
SHOCKING Crypto Leak…
A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
ENOV Mar 2024 60.000 put
ENOV Jun 2024 50.000 put
Altcoin FRENZY Alert…
Bitcoin recently crossed the highest price in its 15-year history… Less than 2 years after one of the most vicious crypto market meltdowns we've ever seen! Bitcoin's BOOM also sent shockwaves through the altcoin market, with select coins seeing HUGE moves in a matter of days… Like Fetch.ai, that gained over 350% in just the last 30 days…
Q4 2023 Enovis Corp Earnings Call
Enovis Announces Fourth Quarter and Full Year 2023 Results
Enovis Announces Fourth Quarter and Full Year 2023 Results
Enovis Corporation Q4 2023 Earnings Preview
ENOV Mar 2024 70.000 call
5 Analysts Have This To Say About Enovis
See More Headlines
Receive ENOV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Enovis and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/22/2024
Today
3/29/2024
Next Earnings (Estimated)
5/02/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Specialty Industrial Machinery
Sub-Industry
N/A
Employees
6,550
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$75.43
High Stock Price Target
$82.00
Low Stock Price Target
$70.00
Potential Upside/Downside
+20.9%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
8 Analysts

Profitability

Net Income
$-33,260,000.00
Pretax Margin
-3.93%

Debt

Sales & Book Value

Annual Sales
$1.71 billion
Cash Flow
$6.62 per share
Book Value
$62.66 per share

Miscellaneous

Free Float
51,834,000
Market Cap
$3.42 billion
Optionable
Optionable
Beta
1.98
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

ENOV Stock Analysis - Frequently Asked Questions

Should I buy or sell Enovis stock right now?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Enovis in the last year. There are currently 8 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" ENOV shares.
View ENOV analyst ratings
or view top-rated stocks.

What is Enovis' stock price target for 2024?

8 Wall Street research analysts have issued 12-month price targets for Enovis' stock. Their ENOV share price targets range from $70.00 to $82.00. On average, they predict the company's share price to reach $75.43 in the next year. This suggests a possible upside of 20.9% from the stock's current price.
View analysts price targets for ENOV
or view top-rated stocks among Wall Street analysts.

How have ENOV shares performed in 2024?

Enovis' stock was trading at $56.02 at the beginning of the year. Since then, ENOV shares have increased by 11.4% and is now trading at $62.38.
View the best growth stocks for 2024 here
.

When is Enovis' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024.
View our ENOV earnings forecast
.

How were Enovis' earnings last quarter?

Enovis Co. (NYSE:ENOV) issued its earnings results on Thursday, February, 22nd. The company reported $0.79 EPS for the quarter, beating the consensus estimate of $0.76 by $0.03. The business had revenue of $455 million for the quarter, compared to analyst estimates of $444.34 million. Enovis had a positive trailing twelve-month return on equity of 3.84% and a negative net margin of 1.95%. The business's revenue for the quarter was up 11.2% on a year-over-year basis. During the same period last year, the company posted $0.72 EPS.

What ETFs hold Enovis' stock?
What guidance has Enovis issued on next quarter's earnings?

Enovis issued an update on its FY24 earnings guidance on Thursday, February, 22nd. The company provided earnings per share guidance of $2.50-$2.65 for the period, compared to the consensus estimate of $2.70. The company issued revenue guidance of $2.05-$2.15 billion, compared to the consensus revenue estimate of $2.02 billion.

Who are Enovis' major shareholders?

Enovis' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (8.98%), Vanguard Group Inc. (8.97%), Dimensional Fund Advisors LP (5.85%), DAVENPORT & Co LLC (3.44%), Channing Capital Management LLC (2.91%) and Allspring Global Investments Holdings LLC (1.89%). Insiders that own company stock include A Clayton Perfall, Bradley J Tandy, Brady Shirley, Christopher M Hix, Daniel A Pryor, John Kleckner, Matthew L Trerotola, Patricia A Lang, Phillip Benjamin (Ben) Berry and Rajiv Vinnakota.
View institutional ownership trends
.

How do I buy shares of Enovis?

Shares of ENOV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:ENOV) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners